The Allstate Corporation

New York Stock Exchange
Back to all articles
Bullish +65

Arrowstreet Capital Limited Partnership Increases Holdings in The ...

📈 Arrowstreet Capital increased its Allstate holdings by 31.5% in Q1, adding 182,977 shares to a total stake worth $158.4 million.

🏦 Multiple institutional investors including Mitsubishi UFJ and Strategic Global Advisors also lifted their stakes in the fourth quarter.

💰 Allstate reported Q1 EPS of $10.65, significantly topping analyst estimates of $7.31 by $3.34.

📊 Revenue reached $16.94 billion for the quarter, marking a 3.0% increase compared to the same period last year.

📉 Net margin stood at 17.81% with a robust return on equity of 42.66%.

💵 A quarterly dividend of $1.08 per share is scheduled for payment on October 1st.

👔 Director Andrea Redmond sold 2,225 shares and COO Mario Rizzo sold 18,578 shares in recent insider transactions.

📉 Insiders have collectively sold 22,353 shares valued at $4.85 million over the last 90 days.

🎯 Morgan Stanley raised its price target to $240 and Atlantic Securities set a target of $319.

🏆 The company maintains a consensus 'Moderate Buy' rating with an average analyst price target of $254.80.

Bullish Signals
  • Allstate reported EPS of $10.65, which is $3.34 higher than the consensus estimate of $7.31.
  • Revenue grew by 3.0% year-over-year to reach $16.94 billion for the quarter.
  • The company achieved a net margin of 17.81% and a return on equity of 42.66%.
  • Arrowstreet Capital increased its position by 31.5%, signaling strong institutional confidence.
  • Morgan Stanley raised its price target to $240, while Atlantic Securities set a high target of $319.
  • The company declared a quarterly dividend of $1.08 per share with an annualized yield of 1.7%.
Risk Factors
  • Insiders sold a total of 22,353 shares valued at $4.85 million over the last 90 days.
  • Zacks Research lowered its rating from 'strong-buy' to 'hold' in an April note.
Full Analysis
Arrowstreet Capital Limited Partnership significantly increased its stake in The Allstate Corporation (NYSE:ALL) by 31.5% during the first quarter, purchasing an additional 182,977 shares to hold a total of 764,096 shares valued at $158.4 million. This move aligns with other institutional investors who also adjusted their positions in the insurance provider's stock during the fourth quarter, including Mitsubishi UFJ Asset Management and Mezzasalma Advisors. Allstate reported strong financial performance for the quarter ended April 29th, issuing earnings per share of $10.65 which substantially beat the consensus estimate of $7.31. The company generated revenue of $16.94 billion, representing a 3.0% year-over-year increase, while achieving a net margin of 17.81% and a return on equity of 42.66%. Analysts expect full-year earnings per share to reach $30.51. The company announced a quarterly dividend of $1.08 per share payable on October 1st for shareholders of record on August 31st, resulting in an annualized dividend yield of 1.7%. Recent insider trading activity includes sales by Director Andrea Redmond and COO Mario Rizzo, with insiders collectively selling shares valued at approximately $4.85 million over the last 90 days. Equity research analysts have provided mixed but generally positive outlooks for Allstate, with price targets ranging from $215 to $319. Major firms like Morgan Stanley and Atlantic Securities raised their price targets to $240 and $319 respectively, while the consensus rating remains a 'Moderate Buy' with an average price target of $254.80.